ascopubs.org

Cost-Utility Analysis of Chemotherapy Using Paclitaxel, Docetaxel, or Vinorelbine for Patients With Anthracycline-Resistant Breast Cancer

PURPOSE: Paclitaxel, docetaxel, and vinorelbine have been approved for chemotherapy in patients with advanced breast cancer that is resistant to anthracyclines. Selecting which agent to use is ...
Medscape

Cost–Utility Analysis of Nanoparticle Albumin-Bound Paclitaxel versus Paclitaxel in Monotherapy in Pretreated Metastatic Breast Cancer in Spain

† Ex-factory price of nab-paclitaxel [105] and ex-factory generic and brand prices of sb-paclitaxel from the Spanish reference price list [104]. ‡ Time of day-hospital occupancy (per cycle): ...
ascopubs.org

Cost-Utility Analysis of Chemotherapy Using Paclitaxel, Docetaxel, or Vinorelbine for Patients With Anthracycline-Resistant Breast Cancer

Abstract PURPOSE: Paclitaxel, docetaxel, and vinorelbine have been approved for chemotherapy in patients with advanced breast cancer that is resistant to anthracyclines. Selecting which agent to use ...